These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9762390

  • 21. Flushing in a menopausal woman taking venlafaxine.
    Grady-Weliky TA, Hartmann DM.
    Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
    [No Abstract] [Full Text] [Related]

  • 22. A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
    Denys D, Kavelaars A, Heijnen CJ, Westenberg H.
    Psychopharmacology (Berl); 2002 Dec; 164(4):432. PubMed ID: 12457275
    [No Abstract] [Full Text] [Related]

  • 23. Comparing the efficacy and safety of fluoxetine and venlafaxine in outpatient depression.
    Michelson D.
    J Clin Psychiatry; 1999 May; 60(5):338-40. PubMed ID: 10362446
    [No Abstract] [Full Text] [Related]

  • 24. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
    Hsiao MC, Liu CY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):576. PubMed ID: 17889418
    [No Abstract] [Full Text] [Related]

  • 25. Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.
    Liberek C, Aubry JM, Baud P.
    Therapie; 2006 Feb 15; 61(6):531-3. PubMed ID: 17348610
    [No Abstract] [Full Text] [Related]

  • 26. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
    Weiss NT, Jones L, Chamberlain JC.
    J Clin Psychiatry; 2004 Oct 15; 65(10):1431-3. PubMed ID: 15491252
    [No Abstract] [Full Text] [Related]

  • 27. Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Jaffe IA.
    Lancet; 1995 May 27; 345(8961):1378. PubMed ID: 7752794
    [No Abstract] [Full Text] [Related]

  • 28. Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants.
    Ashton AK, Longdon MC.
    Am J Psychiatry; 2007 Jul 27; 164(7):1121-2. PubMed ID: 17606668
    [No Abstract] [Full Text] [Related]

  • 29. Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.
    Wang J, Greenberg H.
    J Clin Sleep Med; 2013 Jul 15; 9(7):715-6. PubMed ID: 23853567
    [Abstract] [Full Text] [Related]

  • 30. Withdrawal reactions associated with low-dose venlafaxine treatment in a patient with premenstrual dysphoric disorder.
    Hsiao MC, Liu CY.
    J Clin Psychiatry; 2004 Aug 15; 65(8):1147-8. PubMed ID: 15323606
    [No Abstract] [Full Text] [Related]

  • 31. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A.
    Can J Psychiatry; 2005 Nov 15; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract] [Full Text] [Related]

  • 32. Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.
    Orenstein H, Raskind MA.
    J Clin Psychiatry; 2010 Jan 15; 71(1):89-91. PubMed ID: 20129010
    [No Abstract] [Full Text] [Related]

  • 33. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA, Mourad L, ter Haar J, Egberts AC.
    Ned Tijdschr Geneeskd; 2003 Jul 12; 147(28):1370-2. PubMed ID: 12892015
    [Abstract] [Full Text] [Related]

  • 34. Treatment for hot flushes in women receiving tamoxifen.
    Bydder SA, Spry NA.
    Med J Aust; 2002 Sep 02; 177(5):266. PubMed ID: 12197825
    [No Abstract] [Full Text] [Related]

  • 35. Medication-associated somnambulism.
    Lange CL.
    J Am Acad Child Adolesc Psychiatry; 2005 Mar 02; 44(3):211-2. PubMed ID: 15725964
    [No Abstract] [Full Text] [Related]

  • 36. Venlafaxine-induced urinary incontinence resolved after switching to sertraline.
    Polimeni G, Salvo F, Cutroneo P, Nati G, Russo A, Giustini ES, Spina E.
    Clin Neuropharmacol; 2005 Mar 02; 28(5):247-8. PubMed ID: 16239768
    [Abstract] [Full Text] [Related]

  • 37. [Development of (hypo)mania during discontinuation of venlafaxine in two patients with bipolar disorder].
    Tak LM, Stevens AW.
    Tijdschr Psychiatr; 2013 Mar 02; 55(10):795-800. PubMed ID: 24166339
    [Abstract] [Full Text] [Related]

  • 38. Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders.
    Altamura AC, Pioli R, Vitto M, Mannu P.
    Int Clin Psychopharmacol; 1999 Jul 02; 14(4):239-45. PubMed ID: 10468317
    [Abstract] [Full Text] [Related]

  • 39. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M.
    Rev Med Liege; 1998 Feb 02; 53(2):106-8. PubMed ID: 9564231
    [Abstract] [Full Text] [Related]

  • 40. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG, Cold JA, Jann MW.
    Pharmacotherapy; 1997 Feb 02; 17(3):511-30. PubMed ID: 9165554
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.